0001209191-20-026615.txt : 20200501 0001209191-20-026615.hdr.sgml : 20200501 20200501180012 ACCESSION NUMBER: 0001209191-20-026615 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200429 FILED AS OF DATE: 20200501 DATE AS OF CHANGE: 20200501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ridloff Elena CENTRAL INDEX KEY: 0001772518 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 20842131 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 3611 VALLEY CENTRE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-29 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001772518 Ridloff Elena C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130 0 1 0 0 EVP and CFO Common Stock 2020-04-29 4 M 0 10000 25.12 A 10000 D Common Stock 2020-04-29 4 S 0 10000 50.7353 D 0 D Common Stock 2020-04-29 4 M 0 3245 A 3245 D Common Stock 2020-04-30 4 S 0 1050 49.22 D 2195 D Stock Option (Right to Buy) 25.12 2020-04-29 4 M 0 10000 0.00 D 2029-04-29 Common Stock 10000 35547 D Restricted Stock Units 2020-04-29 4 M 0 3245 0.00 D Common Stock 3245 9736 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2019. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $51.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock. The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. 25% of the 45,547 shares originally subject to the stock option vested and became exercisable on April 29, 2020, and the remaining shares vest in 36 equal monthly installments thereafter. The restricted stock units vest in four equal annual installments beginning 4/29/2020. /s/ Austin D. Kim, Attorney-in-Fact 2020-05-01